News

August 15, 2007 — ProSolv CardioVascular, a FUJIFILM company, announced that it is the newest MedAxiom Corporate Partner.

Home August 14, 2007
Home
News

August 15, 2007 - InspireMD announced today receipt of orders for its MGuard Coronary stents from key markets in Western ...

Home August 14, 2007
Home
News

August 14, 2007 — ProSolv CardioVascular, a FUJIFILM company, announced today that it is the newest MedAxiom corporate ...

Home August 14, 2007
Home
News

August 15, 2007 - Thoratec Corp., a world leader in products to treat cardiovascular disease, said today that its PMA (PreMarket Application) seeking approval of its HeartMate II for bridge-to-transplantation will undergo review by an FDA advisory panel later this year.

Home August 14, 2007
Home
News

August 14, 2007 – GlobalMedTek recently announced a revision of its Version 1.0 for its Medical Software Directory ...

Home August 13, 2007
Home
News

August 14, 2007 - High-speed dual-source computed tomography (DSCT) angiography was 95 percent sensitive and 95 percent ...

Home August 13, 2007
Home
News

August 14, 2007 - Baseline serum complement component C4 is among independent predictors of stroke in patients with known or suspected coronary artery disease.

Home August 13, 2007
Home
News

August 14, 2007 - ELA Medical Inc., a Sorin Group company that specializes in the design and manufacture of implantable ...

Home August 13, 2007
Home
News

Aug 13, 2007 - Medtronic Inc. has entered into a definitive agreement with Biophan Technologies Inc. to acquire its MRI ...

Home August 12, 2007
Home
News

August 13, 2007 – A study published in the Journal of the American College of Cardiology showed that when AngioJet thrombectomy is used to remove large thrombus before placement of a drug-eluting stent (DES), it is associated with significantly lower rates of subsequent death, repeat heart attack and stent thrombosis.

Home August 12, 2007
Home
News

August 9, 2007 - Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it, according to a study published in The American Journal of Medicine by Yale and University of Mi

Home August 08, 2007
Home
News

Aug. 9, 2007 - Abiomed Inc. today announced financial results for its first quarter of fiscal 2008 with record revenue ...

Home August 08, 2007
Home
News

August 8, 2007 - Orbotech Ltd. announced that it has signed a definitive agreement to acquire 3D - Danish Diagnostic ...

Home August 07, 2007
Home
News

August 8, 2007 – Emageon Inc. reported financial results for its second quarter ended June 30, 2007, reflecting net ...

Home August 07, 2007
Home
News

August, 8, 2007 - The Medicines Company announced that the new guidelines released yesterday by the American College of ...

Home August 07, 2007
Home
Subscribe Now